Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Gilead Sciences, Inc.    GILD

GILEAD SCIENCES, INC.

(GILD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization1 93 58180 91682 20973 03176 967-
Entreprise Value (EV)1 119 53578 44982 450103 91094 50587 086
P/E ratio 20,4x15,0x15,4x583x11,3x11,5x
Yield 2,90%3,65%3,88%4,67%4,60%4,71%
Capitalization / Revenue 3,58x3,66x3,66x2,96x3,10x3,23x
EV / Revenue 4,58x3,55x3,67x4,21x3,80x3,66x
EV / EBITDA 6,90x6,11x6,61x7,74x7,30x7,76x
Price to Book 4,57x3,75x3,65x4,04x3,30x3,03x
Nbr of stocks (in thousands) 1 306 2691 293 6201 265 1461 253 5281 253 528-
Reference price (USD) 71,662,665,058,361,461,4
Last update 02/06/201802/04/201902/04/202002/04/202102/11/202102/11/2021
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales1 26 10722 12722 44924 68924 85723 802
EBITDA1 17 31712 84012 46813 14212 95311 218
Operating profit (EBIT)1 16 03111 41111 06411 70412 38811 305
Operating Margin 61,4%51,6%49,3%47,4%49,8%47,5%
Pre-Tax Profit (EBT)1 13 5297 7995 1601 6699 0868 445
Net income1 4 6285 4555 3861237 2366 758
Net margin 17,7%24,7%24,0%0,50%29,1%28,4%
EPS2 3,514,174,220,105,415,32
Dividend per Share2 2,082,282,522,722,822,89
Last update 02/06/201802/04/201902/04/202002/04/202102/15/202102/15/2021
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt1 25 954-24130 87917 53810 119
Net Cash position1 -2 467----
Leverage (Debt / EBITDA) 1,50x-0,19x0,02x1,89x1,35x0,90x
Free Cash Flow1 11 3087 4768 3197 4119 6729 259
ROE (Net Profit / Equities) 58,5%41,5%38,3%43,8%27,5%26,9%
Shareholders' equity1 7 91513 13614 05528126 30525 138
ROA (Net Profit / Asset) 18,3%8,14%8,60%0,19%11,5%10,4%
Assets1 25 26966 97962 65165 07963 13364 698
Book Value Per Share2 15,716,717,814,418,620,3
Cash Flow per Share2 9,026,427,166,096,626,01
Capex1 590924825768754747
Capex / Sales 2,26%4,18%3,67%3,14%3,03%3,14%
Last update 02/06/201802/04/201902/04/202002/04/202102/19/202102/19/2021
1 USD in Million
2 USD
Estimates
Finances - Leverage
Financial data source
© 2021 S&P Global Market Intelligence
Key data
Capitalization (USD)
76 966 628 348
Net sales (USD)
22 449 000 000
Number of employees
11 800
Sales / Employee (USD)
1 902 458
Free-Float
99,6%
Free-Float capitalization (USD)
76 694 441 545
Avg. Exchange 20 sessions (USD)
540 583 151
Average Daily Capital Traded
0,70%
EPS & Dividend